Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$5.98 - $7.51 $111,239 - $139,701
-18,602 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$6.98 - $11.29 $129,841 - $210,016
18,602 New
18,602 $136,000
Q4 2018

Feb 14, 2019

SELL
$5.18 - $9.35 $99,430 - $179,473
-19,195 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$6.0 - $11.35 $115,170 - $217,863
19,195 New
19,195 $169,000

Others Institutions Holding RDHL

About RedHill Biopharma Ltd.


  • Ticker RDHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 63,823,500
  • Market Cap $465M
  • Description
  • RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...
More about RDHL
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.